Elizabeth C. Verna

14.2k total citations · 1 hit paper
185 papers, 5.9k citations indexed

About

Elizabeth C. Verna is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Elizabeth C. Verna has authored 185 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Hepatology, 99 papers in Epidemiology and 62 papers in Surgery. Recurrent topics in Elizabeth C. Verna's work include Liver Disease Diagnosis and Treatment (87 papers), Liver Disease and Transplantation (85 papers) and Organ Transplantation Techniques and Outcomes (38 papers). Elizabeth C. Verna is often cited by papers focused on Liver Disease Diagnosis and Treatment (87 papers), Liver Disease and Transplantation (85 papers) and Organ Transplantation Techniques and Outcomes (38 papers). Elizabeth C. Verna collaborates with scholars based in United States, United Kingdom and Canada. Elizabeth C. Verna's co-authors include Robert S. Brown, Jennifer C. Lai, Susan Lucak, Jean C. Emond, Marcus R. Pereira, Alberto Larghi, Paul D. Berk, Peter D. Stevens, Jacqueline G. O’Leary and Karim J. Halazun and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elizabeth C. Verna

176 papers receiving 5.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement

2020 338 citations Elizabeth C. Verna et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth C. Verna United States	42	3.0k	2.7k	1.9k	1.0k	780	185	5.9k
Thomas D. Schiano United States	47	5.2k 1.8×	4.3k 1.6×	3.6k 1.9×	416 0.4×	460 0.6×	380	9.2k
Aijaz Ahmed United States	53	5.5k 1.9×	7.8k 2.9×	1.8k 1.0×	613 0.6×	600 0.8×	322	10.7k
A. Sidney Barritt United States	33	1.6k 0.5×	2.4k 0.9×	2.0k 1.1×	460 0.4×	868 1.1×	125	5.1k
Joseph K. Lim United States	49	4.5k 1.5×	5.6k 2.1×	1.8k 1.0×	995 1.0×	1.5k 1.9×	211	9.0k
Eric M. Yoshida Canada	46	5.7k 1.9×	5.4k 2.0×	1.8k 0.9×	1.1k 1.0×	611 0.8×	383	8.8k
S. Fagiuoli Italy	40	3.6k 1.2×	3.1k 1.2×	1.3k 0.7×	435 0.4×	474 0.6×	231	5.7k
Luiz Augusto Carneiro D’Albuquerque Brazil	30	1.6k 0.5×	1.1k 0.4×	1.9k 1.0×	282 0.3×	424 0.5×	336	3.8k
Lorenzo D’Antiga Italy	30	901 0.3×	949 0.4×	2.2k 1.2×	1.5k 1.4×	475 0.6×	155	4.7k
José Luís Calleja Spain	40	4.4k 1.5×	4.2k 1.6×	1.4k 0.7×	521 0.5×	323 0.4×	267	6.1k
Hugo E. Vargas United States	49	5.3k 1.8×	4.4k 1.6×	2.0k 1.0×	383 0.4×	215 0.3×	205	6.9k

Countries citing papers authored by Elizabeth C. Verna

Since Specialization

Citations

This map shows the geographic impact of Elizabeth C. Verna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth C. Verna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth C. Verna more than expected).

Fields of papers citing papers by Elizabeth C. Verna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth C. Verna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth C. Verna. The network helps show where Elizabeth C. Verna may publish in the future.

Co-authorship network of co-authors of Elizabeth C. Verna

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth C. Verna. A scholar is included among the top collaborators of Elizabeth C. Verna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth C. Verna. Elizabeth C. Verna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lai, Jennifer C., Amy M. Shui, Michele Molinari, et al.. (2025). The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality. Hepatology. 83(2). 294–303.

Wang, Melinda, Sy Han Chiou, Daniel Ganger, et al.. (2024). Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Hepatology. 81(4). 1269–1275. 3 indexed citations

Cullaro, Giuseppe, Andrew S. Allegretti, Kavish R. Patidar, Elizabeth C. Verna, & Jennifer C. Lai. (2024). Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis. Liver Transplantation. 31(1). 24–31. 2 indexed citations

Wang, Melinda, Amy M. Shui, Chiung‐Yu Huang, et al.. (2024). The Liver Frailty Index enhances mortality risk prediction above and beyond MELD 3.0 alone. Liver Transplantation. 30(12). 1326–1329. 3 indexed citations

Ventura‐Cots, Meritxell, Yu Jun Wong, Joan Genescà, et al.. (2024). Relationship between updated MELD and prognosis in alcohol-associated hepatitis: Opportunities for more efficient trial design. Hepatology Communications. 8(8). 2 indexed citations

Hwang, Soo Young, et al.. (2024). Racial Disparities of Alcohol-Associated Liver Disease and Its Complications in Hospitalized Patients With Alcohol Use Disorder. SHILAP Revista de lepidopterología. 4(4). 100592–100592.

Wang, Melinda, Amy M. Shui, Elizabeth C. Verna, et al.. (2023). The tele-liver frailty index (TeLeFI): development of a novel frailty tool in patients with cirrhosis via telemedicine. American Journal of Transplantation. 23(7). 966–975. 10 indexed citations

Mahmud, Nadim, Justin Boike, Bartley Thornburg, et al.. (2023). The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology. 77(6). 2041–2051. 7 indexed citations

Wang, Melinda, Amy M. Shui, Jessica M. Ruck, et al.. (2023). The liver frailty index is a predictor of healthcare utilization after liver transplantation in older adults. Clinical Transplantation. 38(1). e15219–e15219. 5 indexed citations

10.

Wang, Xiaobo, Hongxue Shi, Changyu Zhu, et al.. (2021). TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis. Journal of Hepatology. 76(4). 910–920. 32 indexed citations

11.

Eickhoff, Jens C., Meritxell Ventura‐Cots, Juan G. Abraldeṣ, et al.. (2021). The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol‐Associated Hepatitis. Liver Transplantation. 27(10). 1382–1391. 6 indexed citations

12.

Sharma, Pratima, Min Zhang, John C. Magee, et al.. (2021). Renal Outcomes After Simultaneous Liver‐Kidney Transplantation: Results from the US Multicenter Simultaneous Liver‐Kidney Transplantation Consortium. Liver Transplantation. 27(8). 1144–1153. 11 indexed citations

13.

Phipps, Meaghan & Elizabeth C. Verna. (2021). Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. Liver Transplantation. 27(9). 1312–1325. 8 indexed citations

14.

Lai, Jennifer C., Robert S. Rahimi, Elizabeth C. Verna, et al.. (2019). Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 156(6). 1675–1682. 166 indexed citations

15.

Cullaro, Giuseppe, et al.. (2017). Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis. Digestive Diseases and Sciences. 62(12). 3487–3494. 14 indexed citations

16.

Verna, Elizabeth C., et al.. (2015). The Role of Sarcopenia and Frailty in Hepatic Encephalopathy Management. Clinics in Liver Disease. 19(3). 507–528. 28 indexed citations

17.

Verna, Elizabeth C., James R. Burton, Jacqueline G. O’Leary, et al.. (2013). 23 A MULTICENTER STUDY OF PROTEASE INHIBITOR-TRIPLE THERAPY IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS: REPORT FROM THE CRUSH-C GROUP. Journal of Hepatology. 58. S10–S11. 18 indexed citations

18.

Shane, Elizabeth, Adi Cohen, Emily M. Stein, et al.. (2012). Zoledronic Acid Versus Alendronate for the Prevention of Bone Loss after Heart or Liver Transplantation. The Journal of Clinical Endocrinology & Metabolism. 97(12). 4481–4490. 29 indexed citations

19.

Siegel, Abby B., Shuang Wang, Judith S. Jacobson, et al.. (2011). Smoking and hepatocellular carcinoma mortality. Experimental and Therapeutic Medicine. 3(1). 124–128. 11 indexed citations

20.

Verna, Elizabeth C., Jay H. Lefkowitch, & Paul D. Berk. (2010). Chronic Hepatitis C of 28 Years' Duration Characterized by Early Development of Stage 2 (of 4) Fibrosis but No Significant Progression over the Subsequent 18 Years. Seminars in Liver Disease. 30(3). 302–309. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact